Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug Regulation

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1777459

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1777459

Post-Marketing Pharmacovigilance and Medical Information

PUBLISHED:
PAGES: 285 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Post-Marketing Pharmacovigilance and Medical Information Market to Reach US$9.6 Trillion by 2030

The global market for Post-Marketing Pharmacovigilance and Medical Information estimated at US$6.0 Trillion in the year 2024, is expected to reach US$9.6 Trillion by 2030, growing at a CAGR of 8.3% over the analysis period 2024-2030. Spontaneous Reporting Services, one of the segments analyzed in the report, is expected to record a 10.1% CAGR and reach US$4.2 Trillion by the end of the analysis period. Growth in the Intensified ADR Reporting Services segment is estimated at 7.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.6 Trillion While China is Forecast to Grow at 13.2% CAGR

The Post-Marketing Pharmacovigilance and Medical Information market in the U.S. is estimated at US$1.6 Trillion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.1 Trillion by the year 2030 trailing a CAGR of 13.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.1% and 8.0% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.6% CAGR.

Global Post-Marketing Pharmacovigilance and Medical Information Market - Key Trends & Drivers Summarized

Why Is Post-Marketing Pharmacovigilance Essential in the Pharmaceutical Industry?

Post-marketing pharmacovigilance (PV) plays a critical role in ensuring drug safety and efficacy after regulatory approval, addressing potential risks, adverse events (AEs), and long-term effects of pharmaceuticals in real-world use. While clinical trials provide initial safety data, they are often limited in sample size, patient diversity, and duration, making post-market surveillance essential for detecting rare, delayed, or unforeseen adverse reactions. Regulatory agencies such as the FDA (U.S.), EMA (Europe), MHRA (UK), and PMDA (Japan) mandate ongoing drug safety monitoring, ensuring that pharmaceutical companies assess, report, and mitigate risks throughout a drug’s lifecycle.

The increasing complexity of biologics, gene therapies, and personalized medicines has heightened the need for advanced pharmacovigilance strategies. Post-marketing surveillance involves spontaneous reporting systems (SRS), electronic health record (EHR) monitoring, active surveillance, and big data analytics to track real-world drug performance. Additionally, pharmaceutical companies rely on medical information (MI) services to provide accurate, evidence-based responses to healthcare professionals (HCPs), patients, and regulatory bodies, ensuring compliance and transparency in drug safety communication.

How Are Technological Advancements Enhancing Post-Marketing Pharmacovigilance?

Technological innovations such as artificial intelligence (AI), machine learning (ML), big data analytics, and natural language processing (NLP) are revolutionizing pharmacovigilance by improving the speed, accuracy, and automation of adverse event detection. AI-powered algorithms can analyze electronic medical records, social media discussions, and patient-reported outcomes to identify potential safety signals and emerging drug-related risks more efficiently than traditional manual review processes.

Another major advancement is the integration of real-world evidence (RWE) and electronic health records (EHRs) in post-marketing safety studies. Pharmaceutical companies and regulatory agencies are increasingly leveraging RWE analytics to assess long-term safety outcomes, off-label use risks, and drug-drug interactions in broader patient populations. These insights help in making data-driven decisions regarding drug labeling updates, market withdrawals, and risk mitigation strategies.

Cloud-based pharmacovigilance platforms and automation tools are also enhancing case management, signal detection, and regulatory reporting. Many companies are adopting cloud-based adverse event (AE) management systems, allowing for real-time adverse event reporting, automated case processing, and streamlined global safety compliance. The implementation of blockchain technology in drug safety data management is also improving data integrity, security, and traceability, ensuring tamper-proof pharmacovigilance records.

What Are the Key Market Trends Driving the Expansion of Pharmacovigilance and Medical Information Services?

One of the most significant trends shaping the pharmacovigilance industry is the increasing regulatory scrutiny and evolving compliance requirements. Regulatory agencies worldwide are imposing stricter reporting timelines, transparency mandates, and risk minimization strategies, compelling pharmaceutical companies to adopt automated and AI-driven pharmacovigilance systems. The implementation of ICH E2E guidelines on pharmacovigilance planning and ISO IDMP (Identification of Medicinal Products) standards is further driving investments in integrated safety data management platforms.

The rise of patient-centric pharmacovigilance and digital health monitoring is another major trend. With the expansion of mobile health (mHealth), wearable devices, and patient-generated health data (PGHD), drug safety monitoring is becoming more proactive and real-time. Pharmaceutical companies are increasingly using smartphone apps, wearable biosensors, and online patient registries to collect continuous safety data, allowing for early risk detection and personalized pharmacovigilance approaches.

Another key trend is the outsourcing of pharmacovigilance and medical information services to contract research organizations (CROs) and business process outsourcing (BPO) providers. The increasing volume of adverse event (AE) case reports, safety signal assessments, and regulatory filings has led many pharmaceutical companies to outsource post-marketing safety operations to specialized PV service providers and technology vendors. This outsourcing model helps reduce operational costs while ensuring regulatory compliance and data-driven decision-making.

What Factors Are Driving the Growth of the Post-Marketing Pharmacovigilance and Medical Information Market?

The growth in the post-marketing pharmacovigilance and medical information market is driven by several factors, including the increasing incidence of adverse drug reactions (ADRs), rising adoption of AI-driven safety surveillance, and the expansion of global pharmacovigilance regulations. One of the primary drivers is the rising number of newly approved drugs, biosimilars, and combination therapies, which require continuous post-market monitoring to ensure long-term safety and compliance with pharmacovigilance legislation.

Another key growth factor is the expansion of personalized medicine and biologics, which present unique safety challenges due to their targeted mechanisms of action and patient-specific treatment responses. The growing adoption of cell and gene therapies, immunotherapies, and precision oncology drugs has increased the demand for advanced safety surveillance models that integrate genomic and biomarker-driven pharmacovigilance data.

The increasing focus on global harmonization of drug safety regulations is also driving the market forward. Regulatory bodies are collaborating on standardized PV frameworks, digital reporting portals, and cross-border safety data sharing to improve adverse event detection and signal management. Pharmaceutical companies must comply with evolving pharmacovigilance legislation across multiple jurisdictions, driving investments in automated compliance platforms, regulatory intelligence tools, and centralized safety databases.

Additionally, the rise of pharmacovigilance in emerging markets is contributing to market expansion. Countries such as China, India, Brazil, and South Korea are strengthening their national pharmacovigilance programs, enforcing stricter post-market surveillance mandates for both locally manufactured and imported pharmaceutical products. The demand for localized PV expertise, multilingual safety reporting, and region-specific compliance solutions is creating new growth opportunities for pharmacovigilance service providers.

As post-marketing safety requirements become more stringent, pharmaceutical companies will continue to invest in AI-powered safety monitoring, digital health analytics, and patient-centric pharmacovigilance models, ensuring that drug safety remains a top priority in the evolving global healthcare landscape.

SCOPE OF STUDY:

The report analyzes the Post-Marketing Pharmacovigilance and Medical Information market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Service Type (Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services, EHR Mining Services); End-Use (Hospitals End-Use, Research Organizations End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

  • 4C Pharma Solutions
  • Accenture Plc.
  • Allucent
  • APCER Life Sciences
  • ArisGlobal
  • ClinChoice
  • Cognizant Technology Solutions Corporation
  • Ergomed Plc
  • F. Hoffmann-La Roche Ltd.
  • Gilead Sciences
  • ICON Plc
  • Indegene Limited
  • IQVIA
  • Labcorp Drug Development (formerly Covance)
  • Med Communications, Inc.
  • Parexel International Corporation
  • Pharmaceutical Product Development, Inc. (PPD)
  • Syneos Health
  • Veristat
  • Wipro Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP32645

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Post-Marketing Pharmacovigilance and Medical Information - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Increasing Regulatory Scrutiny on Post-Marketing Surveillance Boosts the Demand for Pharmacovigilance Services
    • Growing Focus on Patient Safety and Risk Management Strengthens the Case for Comprehensive Pharmacovigilance Programs
    • Shift Toward Real-Time Monitoring of Adverse Drug Reactions Accelerates Adoption of Advanced Pharmacovigilance Technologies
    • Integration of Artificial Intelligence and Machine Learning in Pharmacovigilance Enhances Data Analysis and Signal Detection
    • Expansion of Global Healthcare Markets and Pharmaceutical Products Drives Demand for Post-Marketing Surveillance Services
    • Post-Marketing Surveillance Becomes a Key Driver of Drug Approval and Market Access Strategies
    • Increased Investment in Automated Pharmacovigilance Systems Accelerates Market Growth
    • Rising Incidence of Drug-Related Side Effects Prompts Heightened Focus on Pharmacovigilance
    • Increased Adoption of Cloud-Based Solutions for Pharmacovigilance Data Management Expands Market Opportunities
    • Digital Transformation and Big Data Analytics Enhance the Efficiency and Accuracy of Post-Marketing Surveillance
    • Growing Global Health Concerns and Emerging Diseases Amplify the Need for Post-Marketing Surveillance in New Markets
    • Implementation of Advanced Medical Information Platforms Increases Access to Critical Drug Data and Enhances Patient Support
    • Increasing Patient Empowerment and Access to Health Information Drives the Growth of Medical Information Services
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Post-Marketing Pharmacovigilance and Medical Information Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Spontaneous Reporting Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Spontaneous Reporting Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Spontaneous Reporting Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Intensified ADR Reporting Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Intensified ADR Reporting Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Intensified ADR Reporting Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Targeted Spontaneous Reporting Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Targeted Spontaneous Reporting Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Targeted Spontaneous Reporting Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Cohort Event Monitoring Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Cohort Event Monitoring Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Cohort Event Monitoring Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for EHR Mining Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for EHR Mining Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for EHR Mining Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Research Organizations End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Post-Marketing Pharmacovigilance and Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Post-Marketing Pharmacovigilance and Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Post-Marketing Pharmacovigilance and Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Post-Marketing Pharmacovigilance and Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Post-Marketing Pharmacovigilance and Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Post-Marketing Pharmacovigilance and Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Post-Marketing Pharmacovigilance and Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Post-Marketing Pharmacovigilance and Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Post-Marketing Pharmacovigilance and Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Post-Marketing Pharmacovigilance and Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Post-Marketing Pharmacovigilance and Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Post-Marketing Pharmacovigilance and Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Post-Marketing Pharmacovigilance and Medical Information Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by Service Type - Percentage Breakdown of Value Sales for Spontaneous Reporting Services, Intensified ADR Reporting Services, Targeted Spontaneous Reporting Services, Cohort Event Monitoring Services and EHR Mining Services for the Years 2015, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Hospitals End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Post-Marketing Pharmacovigilance and Medical Information by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!